Next Article in Journal
Effects of Combined Treatment with Sodium Dichloroacetate and Sodium Valproate on the Genes in Inflammation- and Immune-Related Pathways in T Lymphocytes from Patients with SARS-CoV-2 Infection with Pneumonia: Sex-Related Differences
Previous Article in Journal
Nanomedicine for the Treatment of Viral Diseases: Smaller Solution to Bigger Problems
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Revolutionizing Three-Dimensional Printing: Enhancing Quality Assurance and Point-of-Care Integration through Instrumentation

by
Javier Suárez-González
1,2,
Eduardo Díaz-Torres
1,2,3,*,
Cecilia N. Monzón-Rodríguez
1,
Ana Santoveña-Estévez
1,2,* and
José B. Fariña
1,2
1
Departamento de Ingeniería Química y Tecnología Farmacéutica, Campus de Anchieta, Universidad de La Laguna (ULL), 38200 La Laguna, Spain
2
Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna (ULL), Avenida Astrofísico Francisco Sánchez, s/n., 38200 La Laguna, Spain
3
Programa de Doctorado en Ciencias Médicas y Farmacéuticas, Desarrollo y Calidad de Vida, Universidad de La Laguna, 38200 La Laguna, Spain
*
Authors to whom correspondence should be addressed.
Pharmaceutics 2024, 16(3), 408; https://doi.org/10.3390/pharmaceutics16030408
Submission received: 21 February 2024 / Revised: 12 March 2024 / Accepted: 14 March 2024 / Published: 16 March 2024

Abstract

Three-dimensional printing in the field of additive manufacturing shows potential for customized medicines and solving gaps in paediatric formulations. Despite successful clinical trials, 3D printing use in pharmaceutical point-of-care is limited by regulatory loopholes and a lack of Pharmacopoeia guidelines to ensure quality. Semi-solid extrusion is a 3D printing technology that stands out for its versatility, but understanding the fluid dynamics of the semi-solid mass is critical. The aim of this research is to look into the advantages of instrumenting a 3D printer with a semi-solid extrusion motor-driven printhead, which is able to record the printing pressure over time, for in situ characterization of the semi-solid mass and quality evaluation of dosage forms. Four formulations using hydrochlorothiazide as the active pharmaceutical ingredient and several excipients were used. Their flow properties were studied at different printing speeds and temperatures using traditional techniques (rheometer and Texture Analyzer) and the proposed semi-solid extrusion motor-driven printhead incorporated into a printing platform. In addition, the influence of printing speed in the printing process was also evaluated by the study of printing pressure and printlet quality. The results demonstrated the similarities between the use of a Texture Analyzer and the semi-solid extrusion motor-driven. However, the latter enables temperature selection and printing speed in accordance with the printing process which are critical printing parameters. In addition, due to the incorporation of a sensor, it was possible to conclude, for the first time, that there is a link between changes in essential printing parameters like printing speed or formulations and variations in printing pressure and printlet quality attributes such as the energy require to obtain a single dosage unit, weight or diameter. This breakthrough holds a lot of potential for assuring the quality of 3D printing dosage forms and paving the way for their future incorporation into point-of-care settings.
Keywords: 3D printing; additive manufacturing; semi-solid extrusion; extrusion dynamics; printing speed; temperature control; quality assurance; point-of-care applications; formulation study; printlet 3D printing; additive manufacturing; semi-solid extrusion; extrusion dynamics; printing speed; temperature control; quality assurance; point-of-care applications; formulation study; printlet

Share and Cite

MDPI and ACS Style

Suárez-González, J.; Díaz-Torres, E.; Monzón-Rodríguez, C.N.; Santoveña-Estévez, A.; Fariña, J.B. Revolutionizing Three-Dimensional Printing: Enhancing Quality Assurance and Point-of-Care Integration through Instrumentation. Pharmaceutics 2024, 16, 408. https://doi.org/10.3390/pharmaceutics16030408

AMA Style

Suárez-González J, Díaz-Torres E, Monzón-Rodríguez CN, Santoveña-Estévez A, Fariña JB. Revolutionizing Three-Dimensional Printing: Enhancing Quality Assurance and Point-of-Care Integration through Instrumentation. Pharmaceutics. 2024; 16(3):408. https://doi.org/10.3390/pharmaceutics16030408

Chicago/Turabian Style

Suárez-González, Javier, Eduardo Díaz-Torres, Cecilia N. Monzón-Rodríguez, Ana Santoveña-Estévez, and José B. Fariña. 2024. "Revolutionizing Three-Dimensional Printing: Enhancing Quality Assurance and Point-of-Care Integration through Instrumentation" Pharmaceutics 16, no. 3: 408. https://doi.org/10.3390/pharmaceutics16030408

APA Style

Suárez-González, J., Díaz-Torres, E., Monzón-Rodríguez, C. N., Santoveña-Estévez, A., & Fariña, J. B. (2024). Revolutionizing Three-Dimensional Printing: Enhancing Quality Assurance and Point-of-Care Integration through Instrumentation. Pharmaceutics, 16(3), 408. https://doi.org/10.3390/pharmaceutics16030408

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop